Profiel
Chulho Park is the founder of Oncotelic, Inc. (founded in 2015) where he holds the title of Chief Technology Officer.
He was also the founder of Mabprex, Inc. (founded in 2010) where he held the title of Chief Executive Officer until 2018.
Dr. Park's former jobs include being the Chief Technology Officer at Oncotelic Therapeutics, Inc. from 2019 to 2021 and being the President-Pharmaceutical Development at IgDraSol, Inc. in 2013.
Actieve functies van Chulho Park
| Bedrijven | Functie | Begin |
|---|---|---|
Oncotelic, Inc.
 Oncotelic, Inc. BiotechnologyHealth Technology Oncotelic, Inc. develops a therapeutic platform for cancer treatments. It conducts registration trials for multiple cancer indications including pancreatic, melanoma, and glioblastoma. The company was founded by Vuong Trieu and Chulho Park and is headquartered in Agoura Hills, CA. | Oprichter | 01-01-2015 |
Eerdere bekende functies van Chulho Park
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-07-2021 |
| Mabprex, Inc. | Algemeen Directeur | 01-01-2018 |
IgDraSol, Inc.
 IgDraSol, Inc. Pharmaceuticals: MajorHealth Technology Part of Cambridge Equities LP, IgDraSol, Inc. is a company that manufactures cancer therapeutics. The company is based in Fountain Valley, CA. The company was founded by Larn Hwang, Vuong Trieu. IgDraSol was acquired by NantPharma LLC from Sorrento Therapeutics, Inc. on May 15, 2015 for $1,290 million. | Corporate Officer/Principal | 01-09-2013 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Oncotelic, Inc.
Oncotelic, Inc. BiotechnologyHealth Technology Oncotelic, Inc. develops a therapeutic platform for cancer treatments. It conducts registration trials for multiple cancer indications including pancreatic, melanoma, and glioblastoma. The company was founded by Vuong Trieu and Chulho Park and is headquartered in Agoura Hills, CA. | Health Technology |
IgDraSol, Inc.
IgDraSol, Inc. Pharmaceuticals: MajorHealth Technology Part of Cambridge Equities LP, IgDraSol, Inc. is a company that manufactures cancer therapeutics. The company is based in Fountain Valley, CA. The company was founded by Larn Hwang, Vuong Trieu. IgDraSol was acquired by NantPharma LLC from Sorrento Therapeutics, Inc. on May 15, 2015 for $1,290 million. | Health Technology |
| Mabprex, Inc. |
